Suppr超能文献

一种钙调蛋白拮抗剂可通过单克隆抗体提高与主要组织相容性复合体(MHC)分子结合的脂质体的内吞作用表观速率。

A calmodulin antagonist increases the apparent rate of endocytosis of liposomes bound to MHC molecules via monoclonal antibodies.

作者信息

Truneh A, Mishal Z, Leserman L D

出版信息

Exp Cell Res. 1984 Nov;155(1):50-63. doi: 10.1016/0014-4827(84)90767-5.

Abstract

We have investigated the molecular mechanisms required for endocytosis of MHC-encoded proteins by a cell line, TRH 42, that expresses endogenous murine and introduced human class I molecules. As probes we have used protein A-bearing liposomes which bind to cell surface determinants via monoclonal antibodies. The technique of fluorescence quenching release was used with liposome encapsulated quenched carboxyfluorescein as the marker for endocytosis. We demonstrate that the calmodulin antagonist trifluoperazine (TFP) enhances the apparent rate of endocytosis of liposomes bound to MHC class I molecules. Drugs that interfere with energy metabolism, microfilament organization, or phospholipase A2 activity all block endocytosis both in the presence and absence of TFP. The requirement of extracellular Ca2+ for endocytosis was found to be partial. The implications for the structural and enzymatic requirements of endocytosis of MHC class I molecules are discussed.

摘要

我们研究了TRH 42细胞系对MHC编码蛋白进行内吞作用所需的分子机制,该细胞系表达内源性鼠类和导入的人类I类分子。我们使用了带有蛋白A的脂质体作为探针,其通过单克隆抗体与细胞表面决定簇结合。采用荧光猝灭释放技术,将脂质体包裹的猝灭羧基荧光素作为内吞作用的标记物。我们证明,钙调蛋白拮抗剂三氟拉嗪(TFP)可提高与MHC I类分子结合的脂质体的内吞表观速率。干扰能量代谢、微丝组织或磷脂酶A2活性的药物,无论有无TFP存在,均会阻断内吞作用。发现细胞外Ca2+对内吞作用的需求是部分性的。本文讨论了MHC I类分子内吞作用对结构和酶的要求。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验